You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 20, 2025

Drug Price Trends for NDC 70954-0398


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 70954-0398

Drug NameNDCPrice/Unit ($)UnitDate
DEXAMETHASONE 0.5 MG TABLET 70954-0398-10 0.09289 EACH 2024-12-18
DEXAMETHASONE 0.5 MG TABLET 70954-0398-10 0.09507 EACH 2024-11-20
DEXAMETHASONE 0.5 MG TABLET 70954-0398-10 0.08516 EACH 2024-10-23
DEXAMETHASONE 0.5 MG TABLET 70954-0398-10 0.07559 EACH 2024-09-18
DEXAMETHASONE 0.5 MG TABLET 70954-0398-10 0.07110 EACH 2024-08-21
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 5 of 5 entries

Best Wholesale Price for NDC 70954-0398

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for the Drug NDC: 70954-0398

Overview of NDC 70954-0398

The National Drug Code (NDC) 70954-0398 corresponds to Dexamethasone, a corticosteroid medication manufactured by ANI Pharmaceuticals, Inc.[1].

Drug Description and Uses

Dexamethasone is a synthetic member of the glucocorticoid class of steroid drugs. It has potent anti-inflammatory and immunosuppressive properties, making it widely used in various medical conditions such as allergic reactions, asthma, and certain types of arthritis. It is also used in the treatment of certain cancers and to suppress the immune system in organ transplant patients.

Market Analysis

Current Market Size and Growth

The pharmaceutical market, particularly the segment involving corticosteroids like Dexamethasone, is part of a larger industry that is experiencing significant growth. The biopharma market, which includes drugs like Dexamethasone, was estimated to be over $400 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.56% between 2024 and 2029[3].

Competitive Landscape

The market for Dexamethasone is competitive, with multiple manufacturers and labelers involved. ANI Pharmaceuticals, Inc., the manufacturer of NDC 70954-0398, operates in a market that includes other major players such as Novitium Pharma LLC, which also produces various pharmaceuticals under the same NDC labeler code[1].

Regulatory Environment

The regulatory landscape for pharmaceuticals is evolving to keep pace with innovation. This includes changes in clinical trial designs and regulatory frameworks that could impact the development and approval of new drugs, as well as the pricing and availability of existing ones[3].

Price Projections

Historical Pricing

While specific historical pricing data for NDC 70954-0398 is not provided in the sources, the general trend in the pharmaceutical industry suggests that prices can fluctuate based on various factors such as production costs, market demand, and regulatory changes.

Factors Influencing Pricing

Several factors can influence the pricing of Dexamethasone:

  • Production Costs: Increases in raw material costs or manufacturing expenses can lead to higher prices.
  • Market Demand: High demand, especially during public health crises or for essential medications, can drive up prices.
  • Regulatory Changes: Changes in FDA regulations or approval processes can impact pricing strategies.
  • Competitive Market: The presence of multiple manufacturers can lead to competitive pricing.

Future Price Projections

Given the overall growth in the pharmaceutical market and the specific trends in the biopharma sector, it is likely that the price of Dexamethasone will remain stable or see moderate increases. Here are some key points to consider:

  • Inflation and Economic Factors: General economic conditions, such as inflation, can influence the pricing of pharmaceuticals.
  • Technological Advancements: Improvements in manufacturing processes could reduce costs and stabilize prices.
  • Regulatory Approvals: New approvals or changes in regulatory status could impact pricing strategies.

Example Pricing Trends in Similar Markets

For instance, the pricing of other pharmaceutical products has shown variability based on market conditions. The price of Dapsone 5% Gel, another pharmaceutical product, has fluctuated over time, with prices per unit ranging from $1.37 to $1.87 between October 2024 and December 2024[2].

Impact of OTC and Prescription Drug Markets

The high cost of prescription drugs is driving a shift towards over-the-counter (OTC) drugs in the United States. However, since Dexamethasone is primarily a prescription drug, its pricing is less likely to be directly influenced by OTC market trends. Nonetheless, the overall pressure on prescription drug prices due to cost concerns could indirectly affect the pricing strategy for Dexamethasone[4].

Conclusion

The market analysis and price projections for the drug NDC 70954-0398, Dexamethasone, indicate a stable to moderately increasing price trend driven by factors such as market demand, production costs, and regulatory changes. The competitive landscape and evolving regulatory environment will continue to shape the pricing strategies for this and similar pharmaceutical products.

Key Takeaways

  • Market Growth: The biopharma market is growing at a CAGR of 7.56% between 2024 and 2029.
  • Regulatory Changes: Evolving clinical trial designs and regulatory frameworks will impact drug development and pricing.
  • Competitive Landscape: Multiple manufacturers are involved in the production of Dexamethasone, influencing pricing strategies.
  • Pricing Factors: Production costs, market demand, and regulatory changes are key factors influencing the price of Dexamethasone.
  • Future Projections: Prices are likely to remain stable or see moderate increases due to economic and technological factors.

FAQs

Q: What is the primary use of Dexamethasone? A: Dexamethasone is used to treat various medical conditions including allergic reactions, asthma, and certain types of arthritis, as well as to suppress the immune system in organ transplant patients.

Q: Who manufactures the drug with NDC 70954-0398? A: The drug with NDC 70954-0398, Dexamethasone, is manufactured by ANI Pharmaceuticals, Inc.

Q: What factors influence the pricing of Dexamethasone? A: The pricing of Dexamethasone is influenced by production costs, market demand, regulatory changes, and the competitive market landscape.

Q: How is the biopharma market expected to grow in the coming years? A: The biopharma market is expected to grow at a CAGR of 7.56% between 2024 and 2029.

Q: What is the impact of OTC drug market trends on prescription drugs like Dexamethasone? A: While the shift towards OTC drugs due to high prescription drug costs does not directly impact Dexamethasone, it can indirectly influence pricing strategies for prescription drugs.

Sources

  1. FindACode: ANI Pharmaceuticals, Inc. - List of Drugs - NDC Labeler/Manufacturer.
  2. DrugPatentWatch: Latest drug prices and trends for NDC 51672-1387.
  3. TFS CRO: 5 Predictions for the Biopharma and Biotech Industries in 2025.
  4. GlobeNewswire: U.S. OTC Drugs Market Forecast Report 2024-2029.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.